AbbVie AIDS Drug Clears Pre-Cancerous Lesions In Kenyan Study

AbbVie Inc. 's AIDS drug Kaletra cleared pre-cancerous cervical lesions from 90 percent of patients in a study in Kenya that may lead to the first non-surgical treatment to prevent a disease that kills a woman every two minutes.

http://ift.tt/1e4eToo